Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Shifting paradigms in multiple sclerosis: from disease-specific, through population-specific toward patient-specific.
New insights into the role of stromal cell-derived factor 1 (SDF-1/CXCL12) in the pathophysiology of multiple sclerosis.
What you cannot get from routine MRI of MS patient and why - The growing need for atrophy assessment and seeing beyond the plaque.
Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosis.
Using A Mixed Methods Approach to Develop A Discrete Choice Experiment In Multiple Sclerosis.
Fatigue predicts disease worsening in relapsing-remitting multiple sclerosis patients.
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis.
Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.
Vitamin D in the healthy and inflamed central nervous system: access and function.
Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk.
Reliability and validity of the function in sitting test in nonambulatory individuals with multiple sclerosis.
Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease.
Role of platelets in neuroinflammation: a wide-angle perspective.
Advances in biomarker research in multiple sclerosis.
The effects of early maternal deprivation on auditory information processing in adult Wistar rats.
Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis.
Comparison of Network Meta-Analysis and Traditional Meta-Analysis for Prevention of Relapses In Multiple Sclerosis.
CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Atypical global Takotsubo syndrome in a patient with acute disseminated encephalomyelitis.
Admission sodium level and prognosis in adult Guillain-Barré syndrome.
Thoracic sensory level as a false localizing sign in cervical spinal cord and brain lesions.
Body mass index influence interferon-beta treatment response in multiple sclerosis.
Disease activity return after natalizumab cessation in multiple sclerosis.
Pages
« first
‹ previous
…
678
679
680
681
682
683
684
685
686
…
next ›
last »